close

Enter

Log in using OpenID

Transdermal Drug Delivery Systems Market To Witness Robust Expansion By 2026

embed
A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes faster healing of injuries on the body, delivers
Transdermal Drug Delivery Systems Market To
Witness Robust Expansion By 2026
Transdermal Drug Delivery Systems Market – Global Industry Insights, Trends,
Outlook, and Opportunity Analysis, 2018-2026
A transdermal drug delivery systems (TDDS) is a medicated adhesive bandage or a patch that is stuck
onto the skin to deliver a dose of drug through the skin and in the bloodstream. This patch promotes
faster healing of injuries on the body, delivers a steady infusion of the drug over a time period and
increases the therapeutic value of drugs by avoiding problem associated with drug. This is a simple
technique in which the patch is placed on the injured part of body, from where the drug slowly
penetrates in to the skin and it heals the injured part. Click To Read More On Transdermal Drug
Delivery Systems Market
The advantages of transdermal drug delivery system are - it is non-invasive, less painful to the patient,
administration of complete dose , provides controlled plasma level of the potent drugs, termination of
therapy is easy at any time if not necessary, it is a cost effective treatment and the bandage or patch is
removable. The main components of TDDS are liner, drug, adhesive, membrane, blacking, matrix filler,
and permeation enhancer. The types of TDDS includes single layer drug in adhesive, multi-layer drug
in adhesive, reservoir, vapor and matrix.
The technological advancement in transdermal drug delivery system is anticipated to serve the market
growth in the near future. The advance technology includes transdermal patch design modification,
incorporation of pressure sensitive adhesives and permeation enhancers that results in the enhancement
of drug diffusion and increased the capacity to hold the drug in excess amount.
Rise in number ofsurgical procedures around the globe and increase in prevalence of
cardiovascular disorders is expected to further bolster the transdermal drug delivery system
market growth
North America and Asia Pacific are expected to lead the highest growth in transdermal drug delivery
system market due to the rise in emergency medical cases and the increase of surgical procedures. As
per the World Health Organization (WHO), the global surgical volume in 2012 was around 312.9
million. The cardiovascular disorders are expected to grow at an exponential stage during the forecast
period, that can be attributed to increase the utilization of transdermal drug delivery systems. According
to the American Heart Association, it was estimated that the incident of heart attack in the U.S. was
around 58000 in 2014, and in 2013 worldwide prevalence of stroke was around 25.7 million. Also as
per the World Health Organization (WHO), it was estimated that in 2015, around 17.7 million people
died from cardiovascular diseases (CVDs) including around 31% of global deaths and among this,
around 7.4% had coronary heart disease.
Ask For Sample Copy Of This Business Research Report :
https://www.coherentmarketinsights.com/insight/request-sample/689
Transdermal Drug Delivery Systems Market by Key Player Includes:
Therapeutics Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu
Pharmaceutical Co.Inc., IBSA Institut Biochimque SA, Mylan N.V. , Pfizer, Inc., TEH SENG
Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., 3M Pharmaceuticals Inc., Actelion
Pharmaceuticals Ltd, Bayer Crop Science Ltd., BioGel Technology Inc., Upsher-Smith Laboratories,
Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals,
Inc., Noven Pharmaceuticals Inc., Boehringer Ingelheim GmbH and Actavis Inc.
The growth in various type of diseases such as skin ulcer, acne and skin rash leads the exponential
growth of surgical procedures and hence, this surgeries growth can be attributed to increase in
utilization of transdermal drug delivery systems. As per World Health Organization (WHO), the global
surgical volume in 2012 was around 312.9 million, as the estimated mean global surgical rate was 4469
operations per 100 000 people every year.
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready
syndicated research reports, custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends, technologies, and potential
absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1–206–701–6702
Email: [email protected]
Author
ravikiran
ravikiran184   documents Email
Document
Category
Health and Medicine
Views
10
File Size
365 KB
Tags
system
1/--pages
Report inappropriate content